China's first 1-dose Covid-19 vaccine rolls out; 500m people can be inoculated a year


BEIJING, Feb 28 (Global Times): China's first Ad5-nCoV Covid-19 vaccine was rolled out on Friday (Feb 26). One of the developers of the single-dose vaccine said that the annual production capacity can reach 500 million doses, which means 500 million people can be vaccinated in a year.

Phase-I clinical trials of the vaccine started on March 16, 2020, making it the world's first Covid-19 candidate vaccine that entered clinical trials.

Subscribe now for a chance to win your dream holiday!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Aseanplus News

Government offers RM40,000 incentive to WSC 2024 gold medal winners
Wall St set for higher open as cool inflation data lifts rate cut bets
Asean News Headlines at 10pm on Friday (June 28, 2024)
German John Wick lookalike lands a role in Thai comedy film
Taiwanese singer Jam Hsiao, 37, celebrates wife’s 51st birthday with love profession on public LED screens
No more Doctors Without Borders in Myanmar's northern Rakhine; officials say violence is escalating to dangerous levels
Mongolians vote as anger grows over corruption and economy
Two taken to hospital after accident involving four vehicles at Singapore's Lim Chu Kang
Japan firm probing 76 more deaths in supplement scare
Violent ISIS ideology continues to resonate in region, Singaporeans must stay alert, says home minister

Others Also Read